Sökning: onr:"swepub:oai:lup.lub.lu.se:f845d38a-c511-472a-9bff-92630ca9115c" >
Thrombopoietin rece...
Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
-
- Kapur, Rick (författare)
- Academic Medical Center of University of Amsterdam (AMC),University of Amsterdam
-
- Aslam, Rukhsana (författare)
- Saint Michael's Hospital
-
- Speck, Edwin R. (författare)
- Saint Michael's Hospital
-
visa fler...
-
- Rebetz, Johan M. (författare)
- Lund University,Lunds universitet,Trombocyt immunologi,Forskargrupper vid Lunds universitet,Platelet Immunology,Lund University Research Groups
-
- Semple, John W. (författare)
- Lund University,Lunds universitet,Trombocyt immunologi,Forskargrupper vid Lunds universitet,Platelet Immunology,Lund University Research Groups,Saint Michael's Hospital,University of Toronto
-
visa färre...
-
(creator_code:org_t)
- 2019-05-30
- 2020
- Engelska 4 s.
-
Ingår i: Platelets. - : Informa UK Limited. - 0953-7104 .- 1369-1635. ; 31:3, s. 399-402
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://www.tandfonl...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder in which autoantibodies and/or autoreactive T cells destroy platelets and megakaryocytes in the spleen and bone marrow, respectively. Thrombopoietin receptor agonists (TPO-RA e.g. Romiplostim and Eltrombopag) have made a substantial contribution to the treatment of patients with ITP, which are refractory to first-line treatments and approximately 30% demonstrate sustained elevated platelet counts after drug tapering. How TPO-RA induce these sustained responses is not known. We analyzed the efficacy of a murine TPO-RA in a well-established murine model of active ITP. Treatment with TPO-RA (10 ug/kg, based on pilot dose escalation experiments) significantly raised the platelet counts in ITP-mice. Immunomodulation was assessed by measuring serum IgG anti-platelet antibody levels; TPO-RA-treated mice had significantly reduced IgG anti-platelet antibodies despite the increasing platelet counts. These results suggest that TPO-RA is not only an efficacious therapy but also reduces anti-platelet humoral immunity in ITP.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
Nyckelord
- Immune thrombocytopenia (ITP)
- immunomodulation
- platelet antibodies
- platelet counts
- thrombopoietin receptor agonist (TPO-RA)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas